You are here: Industry Insights > Abbott

News List

RML to appliy Abbott's latest diagnostics technology biospectrumasia
March 07, 2019
Regional Medical Laboratory, Inc., which is part of the Ascension network, partners with Abbott, the global health leader, to advance lab capabilities and help improve health outcomes
Abbott and Novo Nordisk enter partnership to provide integrated digital solution to people with diabetes using insulin worldpharmanews
February 21, 2019
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk...
Abbott India Q3 net profit up marginally to ₹ 117 cr expressbpd
February 11, 2019
Revenue from operations of the company stood at ₹ 947.65 crore for the quarter
Abbott to acquire Cephea Valve Technologies, Inc. pharma
January 17, 2019
Abbott (NYSE: ABT) announced today that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacement technology for people with mitral valve disease.
FDA approves Amplatzer Piccolo Occluder by Abbott biospectrumasia
January 16, 2019
One of the most common congenital heart defects occurring in premature babies, PDA is a potentially life-threatening opening between two blood vessels leading from the heart
AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug expressbpd
December 10, 2018
The company will promote and distribute Dapagliflozin under the brand name GLEDEPA
Abbott recommends rejection of below-market mini-Ttender offer by Baker Mills LLC worldpharmanews
November 15, 2018
Abbott (NYSE: ABT) received notice of an unsolicited mini-tender offer by Baker Mills LLC (Baker Mills) to purchase up to 60,000 Abbott common shares, representing approximately 0.003 percent of the company's outstanding shares.
Abbott’s Portico transcatheter aortic valve reduces severe aortic stenosis expressbpd
September 28, 2018
Patients who received a Portico aortic heart valve had low rates of stroke, death and valve leak; and improved quality of life
Abbott Reports First-Quarter 2018 Results biospace
April 19, 2018
Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2018.
1Q2018 Earnings Call Highlights Abbott’s $7.4 Billion In Sales biospace
April 19, 2018
Abbott today announced financial results for the first quarter ending March 31, 2018. Key takeaways from this morning’s earnings call include:

Previous page 1 2 3 4 5 6 7 Next page